Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2573)
All Articles published online
|
May 21, 2006 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhou J, Fan J, Wang Z, Wu ZQ, Qiu SJ, Huang XW, Yu Y, Sun J, Xiao YS, He YF, Wang YQ, Tang ZY. Conversion to sirolimus immunosuppression in liver transplantation recipients with hepatocellular carcinoma: Report of an initial experience. World J Gastroenterol 2006; 12(19): 3114-3118 [PMID: 16718799 DOI: 10.3748/wjg.v12.i19.3114] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v12/i19/3114.htm |
| Number | Citing Articles |
| 1 |
Gerhard Treiber, Thomas Wex. Targeted Therapies for Hepatocellular Carcinoma. 2011; : 44 doi: 10.2217/ebo.11.316
|
| 2 |
T. Decaens, M. Hurtova, C. Duvoux. Transplantation hépatique pour carcinome hépatocellulaire. Gastroentérologie Clinique et Biologique 2009; 33(1): 61 doi: 10.1016/j.gcb.2008.11.005
|
| 3 |
Celina Ang, Eileen M. O’Reilly, Ghassan K. Abou-Alfa. Multidisciplinary Treatment of Hepatocellular Carcinoma. Recent Results in Cancer Research 2013; 190: 225 doi: 10.1007/978-3-642-16037-0_15
|
| 4 |
K. V. Menon, A. R. Hakeem, N. D. Heaton. Meta‐analysis: recurrence and survival following the use of sirolimus in liver transplantation for hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics 2013; 37(4): 411 doi: 10.1111/apt.12185
|
| 5 |
Mamatha Bhat, Elisa Pasini, Preya Patel, Jeffrey Yu, Cristina Baciu, Sunil M. Kurian, Josh Levitsky. Achieving tolerance modifies cancer susceptibility profiles in liver transplant recipients. Cancer Medicine 2023; 12(4): 5150 doi: 10.1002/cam4.5271
|
| 6 |
Utz Settmacher, Falk Rauchfuß, Michael Bauer, Astrid Bauschke, Susanne Beckebaum, Alfred Königsrainer, Christina Malessa, Silvio Nadalin, Silke Rummler, Andreas Kortgen, Lara Genedy. Organtransplantation mit Lebendspende. 2023; : 129 doi: 10.1007/978-3-662-65736-2_8
|
| 7 |
Taha Z. Shipchandler, Robert R. Lorenz, Walter T. Lee, Aysenur Meric Teker, Olivia Dan, Marshall Strome. Laryngeal Transplantation in the Setting of Cancer: A Rat Model. The Laryngoscope 2008; 118(12): 2166 doi: 10.1097/MLG.0b013e3181855108
|
| 8 |
Quan-Lin Li, Fang-Ming Gu, Zheng Wang, Jia-Hao Jiang, Li-Qing Yao, Chang-Jun Tan, Xiao-Yong Huang, Ai-Wu Ke, Zhi Dai, Jia Fan, Jian Zhou, Xin-yuan Guan. Activation of PI3K/AKT and MAPK Pathway through a PDGFRβ-Dependent Feedback Loop Is Involved in Rapamycin Resistance in Hepatocellular Carcinoma. PLoS ONE 2012; 7(3): e33379 doi: 10.1371/journal.pone.0033379
|
| 9 |
Krishna Menon, Aarathi Vijayashanker, Jamie Murphy, Pål-Dag Line, John Isaac, Anya Adair, Raj Prasad, Douglas Thorburn, Anya Adair, Ian Parker, Lindy Berkman, William Gelson, Rebecca Jones, Derek Manas, Gary Middleton, Jamie Murphy, Praveen Peddu, John Isaac, Thamara Perera, Raj Prasad, Joerg Pollok, Andrew Scarsbrook, Yoh Zen. Liver transplantation for isolated unresectable colorectal liver metastases - Protocol for a service evaluation in the United Kingdom - UKCoMET study. HPB 2023; 25(6): 684 doi: 10.1016/j.hpb.2023.02.011
|
| 10 |
Michael A. Zimmerman, James F. Trotter, Michael Wachs, Thomas Bak, Jeffrey Campsen, Franklin Wright, Tracy Steinberg, William Bennett, Igal Kam. Predictors of long-term outcome following liver transplantation for hepatocellular carcinoma: a single-center experience. Transplant International 2007; 20(9): 747 doi: 10.1111/j.1432-2277.2007.00505.x
|
| 11 |
Mandana Rastegar, Haji-Amin Marjani, Yaghoub Yazdani, Majid Shahbazi, Masoud Golalipour, Touraj Farazmandfar. Investigating Effect of Rapamycin and Metformin on Angiogenesis in Hepatocellular Carcinoma Cell Line. Advanced Pharmaceutical Bulletin 2018; 8(1): 63 doi: 10.15171/apb.2018.008
|
| 12 |
Myron Schwartz, Sasan Roayaie, Manousos Konstadoulakis. Strategies for the management of hepatocellular carcinoma. Nature Clinical Practice Oncology 2007; 4(7): 424 doi: 10.1038/ncponc0844
|
| 13 |
Daniel Palmes, Andree Zibert, Tymotheus Budny, Ralf Bahde, Evgeny Minin, Linus Kebschull, Jens Hölzen, Hartmut Schmidt, Hans-Ullrich Spiegel. Impact of rapamycin on liver regeneration. Virchows Archiv 2008; 452(5): 545 doi: 10.1007/s00428-008-0604-y
|
| 14 |
Toshiyasu Kawahara, Sonal Asthana, Norman M. Kneteman. m-TOR inhibitors: What role in liver transplantation?. Journal of Hepatology 2011; 55(6): 1441 doi: 10.1016/j.jhep.2011.06.015
|
| 15 |
Angel Rubín, Marina Berenguer. Trasplante hepático: inmunosupresión personalizada en pacientes con hepatitis C y carcinoma hepatocelular. Gastroenterología y Hepatología 2013; 36(1): 48 doi: 10.1016/j.gastrohep.2012.03.006
|
| 16 |
Thomas Decaens, Alain Luciani, Emmanuel Itti, Anne Hulin, Françoise Roudot-Thoraval, Alexis Laurent, Elie Serge Zafrani, Ariane Mallat, Christophe Duvoux. Phase II study of sirolimus in treatment-naive patients with advanced hepatocellular carcinoma. Digestive and Liver Disease 2012; 44(7): 610 doi: 10.1016/j.dld.2012.02.005
|
| 17 |
Andreas A. Schnitzbauer, Hans J. Schlitt, Edward K. Geissler. Influence of Immunosuppressive Drugs on the Recurrence of Hepatocellular Carcinoma After Liver Transplantation: A Gap Between Basic Science and Clinical Evidence. Transplantation 2011; 91(11): 1173 doi: 10.1097/TP.0b013e318215e72b
|
| 18 |
Tonghai Xing, Li Huang, Zhenhai Yu, Lin Zhong, Shuyun Wang, Zhihai Peng, Peter Starkel. Comparison of Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Patients with Hepatocellular Carcinoma. PLoS ONE 2013; 8(8): e71251 doi: 10.1371/journal.pone.0071251
|
| 19 |
Yasunobu Matsuda, Takafumi Ichida, Manabu Fukumoto. Hepatocellular carcinoma and liver transplantation: clinical perspective on molecular targeted strategies. Medical Molecular Morphology 2011; 44(3): 117 doi: 10.1007/s00795-011-0547-2
|
| 20 |
Jeffrey Campsen, Michael A Zimmerman, James F Trotter, Michael Wachs, Thomas Bak, Susan Mandell, Igal Kam. Sirolimus and liver transplantation: clinical implications for hepatocellular carcinoma. Expert Opinion on Pharmacotherapy 2007; 8(9): 1275 doi: 10.1517/14656566.8.9.1275
|
| 21 |
Jia Fan, Guang-Shun Yang, Zhi-Ren Fu, Zhi-Hai Peng, Qiang Xia, Chen-Hong Peng, Jian-Ming Qian, Jian Zhou, Yang Xu, Shuang-Jian Qiu, Lin Zhong, Guang-Wen Zhou, Jian-Jun Zhang. Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China. Journal of Cancer Research and Clinical Oncology 2009; 135(10): 1403 doi: 10.1007/s00432-009-0584-6
|
| 22 |
M. Schöniger‐Hekele, C. Müller. Pilot study: rapamycin in advanced hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics 2010; 32(6): 763 doi: 10.1111/j.1365-2036.2010.04404.x
|
| 23 |
Hae Won Lee, Kyung-Suk Suh. Advancements of liver transplantation for hepatocellular carcinoma in Korea. Japanese Journal of Clinical Oncology 2017; 47(2): 93 doi: 10.1093/jjco/hyw168
|
| 24 |
J. Zhou, Z. Wang, Z.-Q. Wu, S.-J. Qiu, Y. Yu, X.-W. Huang, Z.-Y. Tang, J. Fan. Sirolimus-Based Immunosuppression Therapy in Liver Transplantation for Patients With Hepatocellular Carcinoma Exceeding the Milan Criteria. Transplantation Proceedings 2008; 40(10): 3548 doi: 10.1016/j.transproceed.2008.03.165
|
| 25 |
Khaldoun Ghazal, Fabien Stenard, Géraldine Dahlqvist, Clément Barjon, Lynda Aoudjehane, Olivier Scatton, Filomena Conti. Treatment with mTOR inhibitors after liver transplantation enables a sustained increase in regulatory T-cells while preserving their suppressive capacity. Clinics and Research in Hepatology and Gastroenterology 2018; 42(3): 237 doi: 10.1016/j.clinre.2017.10.001
|
| 26 |
Anthony P. Monaco. The Role of mTOR Inhibitors in the Management of Posttransplant Malignancy. Transplantation 2009; 87(2): 157 doi: 10.1097/TP.0b013e318193886e
|
| 27 |
Srinath Chinnakotla, Gary L. Davis, Sugam Vasani, Peter Kim, Koji Tomiyama, Edmund Sanchez, Nicholas Onaca, Robert Goldstein, Marlon Levy, Göran B. Klintmalm. Impact of sirolimus on the recurrence of hepatocellular carcinoma after liver transplantation. Liver Transplantation 2009; 15(12): 1834 doi: 10.1002/lt.21953
|
| 28 |
Laura M. Kulik, Mary F. Mulcahy, Reed A. Omary, Riad Salem. Emerging Approaches in Hepatocellular Carcinoma. Journal of Clinical Gastroenterology 2007; 41(9): 839 doi: 10.1097/MCG.0b013e318060ac52
|
| 29 |
Monika Hurtova, Thomas Decaens, Alexis Laurent, Daniel Cherqui, Christophe Duvoux. Transplantation hépatique pour carcinome hépatocellulaire et chez les malades avec antécédents de cancer. La Presse Médicale 2009; 38(9): 1272 doi: 10.1016/j.lpm.2009.05.001
|
| 30 |
Peng‐Xiang Wang, Yang Xu, Yun‐Fan Sun, Jian‐Wen Cheng, Kai‐Qian Zhou, Sui‐Yi Wu, Bo Hu, Ze‐Fan Zhang, Wei Guo, Ya Cao, Xiao‐Wu Huang, Jian Zhou, Jia Fan, Xin‐Rong Yang. Detection of circulating tumour cells enables early recurrence prediction in hepatocellular carcinoma patients undergoing liver transplantation. Liver International 2021; 41(3): 562 doi: 10.1111/liv.14734
|
| 31 |
Lee S. Nguyen, Mathieu Vautier, Yves Allenbach, Noel Zahr, Olivier Benveniste, Christian Funck-Brentano, Joe-Elie Salem. Sirolimus and mTOR Inhibitors: A Review of Side Effects and Specific Management in Solid Organ Transplantation. Drug Safety 2019; doi: 10.1007/s40264-019-00810-9
|
| 32 |
Wolfgang Sieghart, Thorsten Fuereder, Katharina Schmid, Daniel Cejka, Johannes Werzowa, Fritz Wrba, Xiaowei Wang, Diego Gruber, Susanne Rasoul-Rockenschaub, Markus Peck-Radosavljevic, Volker Wacheck. Mammalian Target of Rapamycin Pathway Activity in Hepatocellular Carcinomas of Patients Undergoing Liver Transplantation. Transplantation 2007; 83(4): 425 doi: 10.1097/01.tp.0000252780.42104.95
|
| 33 |
T. Decaens, C. Duvoux. Carcinome hépatocellulaire et transplantation hépatique : rôle futur des inhibiteurs de la mTOR. Gastroentérologie Clinique et Biologique 2009; 33: S257 doi: 10.1016/S0399-8320(09)73163-X
|
| 34 |
Edward K. Geissler, Andreas A. Schnitzbauer, Carl Zülke, Philipp E. Lamby, Andrea Proneth, Christophe Duvoux, Patrizia Burra, Karl-Walter Jauch, Markus Rentsch, Tom M. Ganten, Jan Schmidt, Utz Settmacher, Michael Heise, Giorgio Rossi, Umberto Cillo, Norman Kneteman, René Adam, Bart van Hoek, Philippe Bachellier, Philippe Wolf, Lionel Rostaing, Wolf O. Bechstein, Magnus Rizell, James Powell, Ernest Hidalgo, Jean Gugenheim, Heiner Wolters, Jens Brockmann, André Roy, Ingrid Mutzbauer, Angela Schlitt, Susanne Beckebaum, Christian Graeb, Silvio Nadalin, Umberto Valente, Victor Sánchez Turrión, Neville Jamieson, Tim Scholz, Michele Colledan, Fred Fändrich, Thomas Becker, Gunnar Söderdahl, Olivier Chazouillères, Heikki Mäkisalo, Georges-Philippe Pageaux, Rudolf Steininger, Thomas Soliman, Koert P. de Jong, Jacques Pirenne, Raimund Margreiter, Johann Pratschke, Antonio D. Pinna, Johann Hauss, Stefan Schreiber, Simone Strasser, Jürgen Klempnauer, Roberto I. Troisi, Sherrie Bhoori, Jan Lerut, Itxarone Bilbao, Christian G. Klein, Alfred Königsrainer, Darius F. Mirza, Gerd Otto, Vincenzo Mazzaferro, Peter Neuhaus, Hans J. Schlitt. Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma. Transplantation 2016; 100(1): 116 doi: 10.1097/TP.0000000000000965
|
| 35 |
Maria Pleguezuelo, Giacomo Germani, Andrew K Burroughs. Evidence‐Based Gastroenterology and Hepatology. 2010; : 685 doi: 10.1002/9781444314403.ch42
|
| 36 |
Oriol Bestard, Josep M. Cruzado, Josep M. Grinyó. Textbook of Organ Transplantation. 2014; : 1134 doi: 10.1002/9781118873434.ch95
|
| 37 |
Nicholas Onaca, Marvin J. Stone, James M. Fulmer, Göran B.G. Klintmalm. Transplantation of the Liver. 2015; : 189 doi: 10.1016/B978-1-4557-0268-8.00016-6
|
| 38 |
Claudia E. Falkensammer, Hugo Bonatti, Juergen Falkensammer, Jaime Aranda-Michel, Rolland C. Dickson, Kelly Norman, Ronald Hinder, Thomas Gonwa, Jeffrey Steers, Winston Hewitt, Justin H. Nguyen. Combined liver transplantation together with partial/total nephrectomy in patients with renal cell cancer and nonalcoholic steatohepatitis. Transplant International 2007; 20(5): 471 doi: 10.1111/j.1432-2277.2006.00442.x
|
| 39 |
Guang-Han Fan, Chen-Zhi Zhang, Feng-Qiang Gao, Xu-Yong Wei, Sun-Bin Ling, Kai Wang, Jian-Guo Wang, Shu-Sen Zheng, Mehrdad Nikfarjam, Xiao Xu. A mixed blessing for liver transplantation patients — Rapamycin. Hepatobiliary & Pancreatic Diseases International 2023; 22(1): 14 doi: 10.1016/j.hbpd.2022.10.004
|
| 40 |
Michael A. Zimmerman, James F. Trotter, Michael Wachs, Tom Bak, Jeffrey Campsen, Afshin Skibba, Igal Kam. Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma. Liver Transplantation 2008; 14(5): 633 doi: 10.1002/lt.21420
|
| 41 |
Jennifer Kim, Eric Huang, Linda Sher, Jose L Almeda. The role of sirolimus in liver transplantation. Current Opinion in Organ Transplantation 2007; 12(6): 636 doi: 10.1097/MOT.0b013e3282f1fbc7
|
| 42 |
N. Mohsin, M. Budruddin, P. Kamble, M. Khalil, A. Pakkyarra, A. Jha, E. Mohammed, H. Ahmed, J. Ahmed, S. Thomas, J.M. Campistol, A. Daar. Complete Regression of Cutaneous B-Cell Lymphoma in a Renal Transplant Patient After Conversion From Cyclosporin to Sirolimus. Transplantation Proceedings 2007; 39(4): 1267 doi: 10.1016/j.transproceed.2007.03.092
|
| 43 |
Zheng Wang, Jian Zhou, Jia Fan, Shuang-Jian Qiu, Yao Yu, Xiao-Wu Huang, Zhao-You Tang. Effect of Rapamycin Alone and in Combination with Sorafenib in an Orthotopic Model of Human Hepatocellular Carcinoma. Clinical Cancer Research 2008; 14(16): 5124 doi: 10.1158/1078-0432.CCR-07-4774
|
| 44 |
S. Fayek, D. Moore, K.H. Bortecen, H. Yeh, J.F. Markmann, K.M. Olthoff, A. Shaked. Liver Transplantation in the Setting of Extra-Hepatic Malignancy: Two Case Reports. Transplantation Proceedings 2007; 39(10): 3512 doi: 10.1016/j.transproceed.2007.09.007
|
| 45 |
A. Moreno, R. Bárcena, M. García-Gonzalez, F. García-Hoz, C. Quereda, J.L. Casado, M.J. Pérez-Elías, J. Fortún, J. Nuño, I. Arranz, S. Moreno. Severe Sirolimus-Related Inflammatory State Anemia in an HIV+ Liver Transplant Patient With Calcineurin Inhibitor Renal Insufficiency: A Case Report. Transplantation Proceedings 2008; 40(10): 3810 doi: 10.1016/j.transproceed.2008.07.130
|
| 46 |
Martin-Walter Welker, Wolf-Otto Bechstein, Stefan Zeuzem, Joerg Trojan. Recurrent hepatocellular carcinoma after liver transplantation - an emerging clinical challenge. Transplant International 2013; 26(2): 109 doi: 10.1111/j.1432-2277.2012.01562.x
|
| 47 |
Gerhard Treiber. mTOR inhibitors for hepatocellular cancer: a forward-moving target. Expert Review of Anticancer Therapy 2009; 9(2): 247 doi: 10.1586/14737140.9.2.247
|
| 48 |
Kyung-Suk Suh, Hae Won Lee. Liver transplantation for advanced hepatocellular carcinoma: how far can we go?. Hepatic Oncology 2015; 2(1): 19 doi: 10.2217/hep.14.34
|
| 49 |
A.O. Ferreiro, M.A. Vazquez-Millán, F.S. López, M.G. Gutiérrez, S.P. Diaz, M.J.L. Patiño. Everolimus-Based Immunosuppression in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Liver Transplantation: A Case Series. Transplantation Proceedings 2014; 46(10): 3496 doi: 10.1016/j.transproceed.2014.08.045
|
| 50 |
A. Hollebecque, T. Decaens, E. Boleslawski, P. Mathurin, C. Duvoux, F.-R. Pruvot, S. Dharancy. Natural history and therapeutic management of recurrent hepatocellular carcinoma after liver transplantation. Gastroentérologie Clinique et Biologique 2009; 33(5): 361 doi: 10.1016/j.gcb.2009.02.036
|
| 51 |
Anantha K. Nuthalapati, Steven I. Hanish, Paul J. Thuluvath. Disease Recurrence After Liver Transplantation. 2016; : 153 doi: 10.1007/978-1-4939-2947-4_11
|